Application Information

This drug has been submitted to the FDA under the reference 017986/001.

Names and composition

"MINIZIDE" is the commercial name of a drug composed of POLYTHIAZIDE and PRAZOSIN HYDROCHLORIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
017986/001 MINIZIDE POLYTHIAZIDE; PRAZOSIN HYDROCHLORIDE CAPSULE/ORAL 0.5MG and EQ 1MG BASE
017986/002 MINIZIDE POLYTHIAZIDE; PRAZOSIN HYDROCHLORIDE CAPSULE/ORAL 0.5MG and EQ 2MG BASE
017986/003 MINIZIDE POLYTHIAZIDE; PRAZOSIN HYDROCHLORIDE CAPSULE/ORAL 0.5MG and EQ 5MG BASE

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
017986/001 MINIZIDE POLYTHIAZIDE; PRAZOSIN HYDROCHLORIDE CAPSULE/ORAL 0.5MG and EQ 1MG BASE
017986/002 MINIZIDE POLYTHIAZIDE; PRAZOSIN HYDROCHLORIDE CAPSULE/ORAL 0.5MG and EQ 2MG BASE
017986/003 MINIZIDE POLYTHIAZIDE; PRAZOSIN HYDROCHLORIDE CAPSULE/ORAL 0.5MG and EQ 5MG BASE

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved